• Nachrichtendetail
• 

11.04.2024 13:19:32 - dpa-AFX: *ASTRAZENECA SAYS FDA APPROVES FASENRA FOR TREATMENT OF CHILDREN AGED 6 TO 11 WITH SEVERE ASTHMA

	Name	WKN	Börse	Kurs	Datum/Zeit	Diff.	Diff. %	Geld	Brief	Erster	Schluss
	ASTRAZENECA PLC DL-,25	886455	Xetra	141,300	29.04.24 17:35:38	+1,000	+0,71%	0,000	0,000	143,050	140,300